Chinese doctors trial plasma therapy on COVID-19 patients
WHO has backed the therapy using convalescent plasma as a 'valid approach'
Doctors in Shanghai are using hyperimmune globulin from plasma of patients who have recovered from COVID-19 to treat those fighting the infection, with some “encouraging preliminary results”.
As of Monday, in Shanghai, China’s financial hub, there had been 332 infected cases. One of those cases has died.
